SEC filings · customer concentration · INBP

Integrated Biopharma's major customers

Integrated Biopharma appears in 1 disclosed customer relationships between 2013 and 2017.

0major customers now
—of revenue from them
0listed suppliers depending on it
2013–2017years covered
Free

Get an email when Integrated Biopharma's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Major customers of Integrated Biopharma

Customers that Integrated Biopharma named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.

Formerly disclosed

CustomerShare of revenueChange vs prior yearHistoryLatest filing
CostcoCOST64%last FY 2017FY 2013: 50%FY 2014: 60%FY 2015: 77%FY 2016: 51%FY 2017: 64%5 yearsFY 2017 · filed 1 Sept 2017

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API